Identification of cyclin D1 (CCND1) and other novel targets for the VHL tumour suppressor gene (TSG) and investigation of CCND1 genotype as a modifier in VHL disease.

被引：0
|
作者：
Zatyka, M
da Silva, NF
Clifford, SC
Morris, MR
Wiesener, MS
Eckardt, KU
Houlston, RS
Richards, FM
Latif, F
Maher, E
机构：
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Humboldt Univ, Charite, Berlin, Germany
[3] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2002年 / 71卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
389
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [31] Cyclin D1 and Non-Small cell lung cancer - a role of CCND1 gene variants in lung carcinogenesis
    Catarino, R.
    Coelho, A.
    Araujo, A.
    Nogal, A.
    Gomes, M.
    Nogueira, A.
    Medeiros, R.
    EJC SUPPLEMENTS, 2009, 7 (02): : 523 - 523
  • [32] Identification of variants in cyclin D1 (CCND1) and B-Cell CLL/lymphoma 2 (BCL2)
    Byung Lae Park
    Lyoung Hyo Kim
    Hyun Sub Cheong
    Hye Young Cho
    Eun Mi Kim
    Hyoung Doo Shin
    Yong-Sun Kim
    Chaeyoung Lee
    Journal of Human Genetics, 2004, 49 : 449 - 454
  • [33] Identification of variants in cyclin D1 (CCND1) and B-cell CLL/lymphoma 2 (BCL2)
    Park, BL
    Kim, LH
    Cheong, HS
    Cho, HY
    Kim, EM
    Shin, HD
    Kim, YS
    Lee, C
    JOURNAL OF HUMAN GENETICS, 2004, 49 (08) : 449 - 454
  • [34] Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas
    Xu, Jia
    Lin, Douglas, I
    PLOS ONE, 2018, 13 (07):
  • [35] CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome
    Elsheikh, Somaia
    Green, Andrew R.
    Aleskandarany, Mohammed A.
    Grainge, Matthew
    Paish, Claire E.
    Lambros, Maryou B. K.
    Reis-Filho, Jorge S.
    Ellis, Ian O.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (02) : 325 - 335
  • [36] Cyclin D1 Overexpression in Hairy Cell Leukemia (HCL) Is Common and Not Related to Structural CCND1 Gene Rearrangements or Gene Amplification
    Seningen, J. L.
    Viswanatha, D. S.
    Ketterling, R. P.
    Knudson, R. A.
    Hoyer, J. D.
    MODERN PATHOLOGY, 2011, 24 : 320A - 320A
  • [37] Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast
    Simpson, JF
    Quan, DE
    OMalley, F
    OdomMaryon, T
    Clarke, PE
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 151 (01): : 161 - 168
  • [38] Splenic marginal zone lymphoma with prolymphocytic transformation and cyclin D1 expression in the absence of CCND1 rearrangement
    Younes, Ismail Elbaz
    Bunting, Silvia T.
    Zhang, Xiaohui
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, : 750 - 754
  • [39] CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome
    Elsheikh, S.
    Green, A. R.
    Paish, E. C.
    Lambros, M. B. K.
    Grainge, M.
    Reis-Filho, J. S.
    Ellis, I. O.
    EJC SUPPLEMENTS, 2007, 5 (03): : 24 - 25
  • [40] Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERβ) in human prostate cancer
    Nakamura, Yasuhiro
    Felizola, Saulo J. A.
    Kurotaki, Yumi
    Fujishima, Fumiyoshi
    McNamara, Keely M.
    Suzuki, Takashi
    Arai, Yoichi
    Sasano, Hironobu
    PROSTATE, 2013, 73 (06): : 590 - 595
12345